P.A. Abrahamsson, Department of Urology, Lund University, Malmö, Sweden
N. Agnantis, Department of Pathology, University of Ioannina Medical School, Ioannina, Greece
F.E. Ahmed, GEM Tox Labs, Institute for Research in Biotechnology, Greenville, NC, USA
C. Alexiou, Division Experimental Oncology/Nanomedicine, Hals-Nasen-Ohren-Klinik/ENT-Clinic, Universitätsklinikum Erlangen, Erlangen, Germany
L. Amaral, Institute of Hygiene & Tropical Medicine, Universidade Nova de Lisboa , Lisbon, Portugal
F.L. Ampil, Department of Radiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA, USA
R. Andersson, Department of Surgery, Faculty of Medicine, Lund University, Lund, Sweden
S. Arbak, Department of Histology and Embryology, Acibadem University School of Medicine, Istanbul, Turkey
V. Barak, Immunology Laboratory for Tumor Diagnosis and Hematology Department, Hadassah – Hebrew University Medical Center, Jerusalem, Israel
D.-T. Bau, Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan
G Bauer, Institute of Virology, Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany
F. Betsou, Integrated BioBank of Luxembourg (IBBL), Luxembourg
A. Bishayee, Department of Pharmaceutical Sciences, School of Pharmacy, American University of Health Sciences, Signal Hill, CA, USA
R. Bjerkvig, Department of Biomedicine, University of Bergen, Bergen, Norway
G. Broich, Coordinatore Sanitario Regionale, Gruppo Policlinico di Monza, Monza, Italy
C. Carlberg, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland
J. Carlsson, Unit of Biomedical Radiation Sciences, Dept. of Radiology, Oncology and Radiation Science, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden
D. Characiejus, Deparment of Pathophysiology and Immunology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
C.J. Chen, Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan
G. Ciarimboli, Experimental Nephrology, Medical Clinic D, Münster University Hospital, Münster, Germany
B.F.C. Clark, Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark
R. Clarke, Department of Oncology, Georgetown University Medical Center , Washington, DC, USA
P. Collery, Society for the Coordination of Therapeutic Researches, Algajola, France
G. Conti, Department of Urology, St. Anna Hospital, Como, Italy
H. Cross, Department of Pathophysiology, Medical University of Vienna, Vienna, Austria
M. De Braekeleer, Laboratoire de Cytogénétique, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France
K. De Meirleir, Himmunitas Foundation, Brussels, Belgium
A.Z. Dudek, Department of Hematology/Oncology, University of Illinois, College of Medicine at Chicago, Chicago, IL, USA
A. Dutour, Department of Clinical Sciences, Centre de Recherche en Cancérologie UMR Inserm U1052, Lyon, France
P. Dziegiel, Department of Histology and Embryology, Medical University of Wroclaw, Wroclaw, Poland
T. Efferth, Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany
W. Engström, Department of Biomedical Sciences and Veterinary Public Health. Faculty of Veterinary Medicine, SLU, Uppsala, Sweden
M. Eskelinen, Department of Surgery, Kuopio University Hospital, Kuopio, Finland
J.A. Fernandez-Pol, Antagoras Agrobusiness, LLC, Chesterfield, MO, USA
A. Fields, Department of Cancer Biology, Mayo Clinic Cancer Center, Jacksonville, FL, USA
M. Friedrich, Department of Gynecology and Obstetrics, HELIOS-Klinikum Krefeld, Krefeld, Germany
R. Friedrich, Department of Oral & Maxillofacial Surgery, Eppendorf University Hospital, Hamburg, Germany
H.-J. Gabius, Department of Physiological Chemistry, Veterinary Sciences Department of Veterinary Medicine Faculty of the
Ludwig-Maximilians-University , Munich, Germany
R. Ganapathi, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA
A.F. Gazdar, The Hamon Center for Therapeutic Oncology Research, U.T. Southwestern Medical Center at Dallas, Dallas, TX, USA
V. Gebbia, Medical Oncology Unit, Dipartimento Oncologico, La Maddalena, Università degli Studi, Palermo, Italy
J.W. Greiner, Laboratory of Tumor Immunology & Biology, CCR, NCI, Bethesda, MD, USA
F.E. Guadagni, SR Research Center, IRCCS San Raffaele Pisana , Rome, Italy
C. Hastie, Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey, UK
J. Hau, Department of Experimental Medicine, University of Copenhagen, Copenhagen, Denmark
R. Hoffman, AntiCancer Inc., San Diego, CA, USA
S. Holdenrieder, Institut für Klinische Chemie und Klinische Pharmakologie-Zentrallabor-Universitätsklinikum Bonn, Bonn, Germany
T. Isbir, Department of Medical Biology, Faculty of Medicine, Yeditepe University, Istanbul, Turkey
S. Jhanwar, Memorial Sloan Kettering Cancer Center, Laboratory of Solid Tumor Genetics, New York, NY, USA
M. Jhanwar-Uniyal, Departmenet of Neurosurgery, New York Medical College, Valhalla, NY, USA
B. Kaina, Institute of Toxicology, Division of Applied Toxicology, University of Mainz, Mainz, Germany
E. Kandil, Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA
Y. Keisari, Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
D.G. Kieback, Klinikum Vest, Standort Marl, Marl, Germany
I. Kiss, Institute of Preventive Medicine, University of Pecs Medical School, Pécs, Hungary
R. Klapdor, Internal Unit, ZeTDT GmbH, Hamburg, Germany
R. Knecht, Department of Otorhinolaryngology, Head and Neck Surgery and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
M. Kohonen-Corish, Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW, Australia
M. Koutsilieris, Laboratory of Experimental Physiology, Department of Basic Sciences, University of Athens Medical School, Athens, Greece
K. Kubota, Second Department of Surgery, Dokkyo Medical University, Mibu, Tochigi, Japan
P.M. Kumar, Division of Laboratory & Regenerative Medicine, University of Manchester Medical School, Manchester, UK
S. Kumar, Department of Biological Sciences, Manchester Metropolitan University, Manchester, UK
O.D. Laerum, Department of Pathology & Oncology, Institute of Clinical Research, Haukeland University Hospital, Bergen, Norway
S.A. Lamprecht, Division of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel
W. Lichtenegger, Charité Campus Virchow-Klinikum, Klinik für Frauenheilkunde und Geburtshilfe, Berlin, Germany
D. Lincoln, Independent Research Foundation, Chapel Hill, QLD, Australia
B. Littlefield, Eisai Inc., Andover, MA, USA
F. Lumachi, University of Padua, School of Medicine, Padova, Italy
G. Martorana, Deprtment of Urology, University of Bologna, Bologna, Italy
S. Mitra, Department of Radiation Oncology, Houston Methodist Research Institute, Galveston, TX, USA
R. Molina, Laboratory of Biochemistry (Oncobiology Unit); Thorax Institute Hospital Clínic, IDIBAPS, Barcelona, Spain
J. Molnar, Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Szeged, Hungary
R. Morgan, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK
N. Motohashi, Department of Medicinal Chemistry, Meiji Pharmaceutical University, Tokyo, Japan
M. Mueller, Department Biomedical Engineering, Faculty of Medical and Life Sciences, Hochschule Furtwangen University, Villingen-Schwenningen, Germany
F.M. Muggia, New York University School of Medicine and NYU Cancer Institute, New York, NY, USA
R.M. Nagler, Department of Oral and Maxillofacial Surgery and Oral Biochemistry Laboratory, Rambam Medical Center and Rappaport Faculty of Medicine, Israel Institute of Technology-Technion, Haifa, Israel
R. Nano, Dipartimento Biologia e Biotecnologie “Lazzaro Spallanzani”, Università degli Studi di Pavia, Pavia, Italy
N. Nguyen, Department of Radiation Oncology, Howard University, Tucson, AZ, USA
C. Nicolini, Laboratories of Biophysics and Nanobiotechnology, Department Experimental Medicine, University of Genova, Genoa, Italy
C. Pace-Asciak, The Hospital for Sick Children Research Institute, Toronto, ON, Canada
S. Pathak, Department of Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
G.J. Pilkington, Cellular and Molecular Neuro-oncology Research Group, University of Portsmouth, Portsmouth, UK
C.D. Platsoucas, College of Sciences, Old Dominion University, Norfolk, VA, USA
A. Polliack, Lymphoma – Leukemia Unit, Department of Hematology, Hadassah University Hospital, Jerusalem, Israel
J. Reichrath, Klinik für Dermatologie, Venerologie und Allergologie; Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
D.A. Ribeiro, Department of Pathology, Paulista Medical School, Federal University of São Paulo, UNIFESP, Santos, SP, Brazil
M. Rigaud, ASTRALAB, Clinical Laboratory, Limoges, France
F.M. Robertson, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
M. Roselli, Department of Systems Medicine, Medical Oncology Unit, Tor Vergata Clinical Center, University of Rome “Tor Vergata”, Rome, Italy
G.R. Rutteman, University Clinic of Companion Animals, Utrecht and Veterinary Specialist Center De Wagenrenk, Wageningen, Netherlands
C. Sansom, Department of Biological Sciences, Birkbeck, University of London, London, UK
S. Sarkar, Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
A. Schauer, Zentrum Pathologie, Georg-August-Universitat-Gottingen, Göttingen, Germany
D. Schiffer, Neuro-bio-oncology Center, Policlinico di Monza Foundation, Vercelli, Italy
J. Schneider, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón (Madrid), Spain
M. Schneider, FB C − Organische Chemie, Bergische Universität Wuppertal, Wuppertal, Germany
O.J. Semmes, Leroy T. Canoles, Jr. Cancer Research Center, Eastern Virginia Medical School , Norfolk, VA, USA
A. Seth, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
G. Sica, Institute of Histology and Embryology, “A. Gemelli” Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy
J. Slansky, Integrated Department of Immunology, School of Medicine, University of Colorado Denver, Denver, CO, USA
K. Smetana, 1st Faculty of Medicine, Institute of Anatomy, Charles University, Prague, Czech Republic
S.S. Smith, NanoLab, Division of Urology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
R.M. Snapka, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
D.D. Spyropoulos, Pathology & Lab Medicine Walton, Medical University of South Carolina, Charleston, SC, USA
J. Sterling, Center for Bone Biology, Department of Medicine, Vanderbilt University, Nashville, TN, USA
T. Stigbrand, Department of Immunology and Immnunochemistry, Umeå University, Umeå, Sweden
K. Syrjänen, Department of Clinical Research, Biohit Oyj, Helsinki, Finland
R.T. Todorova, IBPhBME-BAS, Sofia, Bulgaria
O. Topolcan, Department of Immunoanalysis, Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic
G.C. Torre, Centro Ippocrate, Finale Ligure (SV), Italy
V. Treska, Department of Surgery, University Hospital in Pilsen, Pilsen, Czech Republic
M. de L.G. Trigo, Serviço de Braquiterapia, Instituto Português Oncologia Porto FG, EPE, Porto, Portugal
G. Tsangaris, Central Unit of Genomics-Proteomics, Foundation of Biomedical Research of the Academy of Athens, Athens, Greece
E. Vairaktraris, Clinic for Maxillofacial Surgery, “Attikon” University Hospital, Athens, Greece
D. Vesely, Department of Medicine, James A. Haley VA Medical Center and University of South Florida Morsani Health Sciences Center, Tampa, FL, USA
D. Vetvicka, Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
J.K. Vishwanatha, Department of Molecular and Medical Genetics, University of North Texas Health Science Center, Fort Worth, TX, USA
G. Vollmer, Department of Biology, Technische Universitaet Dresden, Dresden, Germany
A. Wani, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
I.P. Witz, Cancer Microenvironment, Tel-Aviv University, Tel Aviv, Israel
Y. Yen, Department of Molecular Pharmacology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
C.H. Yip, Breast Centre, Subang Jaya Medical Centre, Selangor, Malaysia
O. Zoras, Department of Surgical Oncology. University Hospital of Heraklion, Heraklion, Greece
